<DOC>
	<DOCNO>NCT00491348</DOCNO>
	<brief_summary>( 1 ) compare difference neural activation pathological worry pre-treatment GAD patient normal subject ; ( 2 ) measure difference brain activation worry GAD patient duloxetine treatment</brief_summary>
	<brief_title>Effects Duloxetine Pathological Worry Patients With Generalized Anxiety Disorder : A fMRI Study</brief_title>
	<detailed_description>The study recruit 20 GAD patient 20 healthy control . Both patient control receive medical psychiatric screen procedure visit 1 ask complete three self-rating questionnaire one health questionnaire visit 1 . All qualified participant receive functional magnetic resonance imaging ( fMRI ) baseline . The patient begin treatment duloxetine 30 mg/day visit 2 titrate 60 mg/day visit 3 ( 2 week since drug dispense ) . The dosage maintain 60 mg/day 6 week . During period , patient receive periodic evaluation visit 2 ( 0 week drug dispense ) , 3 ( 2 week since drug dispense ) , 4 ( 4 week since drug dispense ) , 5 ( 8 week since drug dispense ) . The patient receive fMRI examination baseline end 8-week treatment .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>DSMIV criterion generalize anxiety disorder moderate degree Participants 18 year old Major depression Panic disorder Obsessivecompulsive disorder Posttraumatic disorder Eating disorder Psychotic disorder ; Alcohol substance use disorder Neurological disease Cardiovascular disease Respiratory disease Head trauma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Generalized anxiety disorder</keyword>
	<keyword>fMRI</keyword>
	<keyword>Worry</keyword>
</DOC>